Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

New experiments suggest that freezing and thawing on early Earth may have helped primitive cell-like structures grow and evolve. Tiny lipid bubbles behaved very differently depending on their membrane ...

HUMANS HAVE never been immune from the pressures of natural selection. Throughout the history of the species circumstances have arisen to give individuals with certain beneficial mutations an ...

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.03 since the market last closed. This is a 1.11 ...

Natural selection has been playing a bigger role in changing modern human DNA than previously thought, according to a new study. geralt via Wikimedia Commons under CC0 Many people are familiar with ...

A good sum of two good parts. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market cycle on a ...